Wip1-deficient mice are resistant to common cancer genes

Martin Harrison1, Jing Li, Yan Degenhardt

  • 1Tularik Ltd, Aleutian House, Tytherington Business Park, Macclesfield, Cheshire SK19 2XR, UK.

Insights

WIP1 phosphatase is a key driver in some breast cancers. Inhibiting WIP1 shows promise as a broad-spectrum breast cancer treatment, despite challenges in developing inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The PPM1D gene encodes WIP1, a serine-threonine phosphatase.
  • WIP1 is an oncogene associated with a 17q23 amplicon in ~15% of breast tumors.
  • Its role in the remaining 85% of breast cancers is largely unknown.

Purpose of the Study:

  • To investigate the role of WIP1 in breast tumor formation beyond known amplicon-associated cases.
  • To explore the therapeutic potential of targeting WIP1 in breast cancer.

Main Methods:

  • Utilized Wip1-deficient mouse models.
  • Investigated the impact of WIP1 function blockade on RAS and ERBB2-induced breast tumorigenesis.

Main Results:

  • WIP1 deficiency significantly impaired RAS and ERBB2-driven breast tumor formation in mice.
  • This suggests WIP1 plays a crucial role in a broader spectrum of breast cancers.

Conclusions:

  • WIP1 inhibition represents a potential broad-spectrum therapeutic strategy for breast cancer.
  • The complex structure of WIP1 presents challenges for small molecule inhibitor development.

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...